Apatinib as an Alternative for Advanced Non-Small Cell Lung Cancer

被引：0
|
作者：
Wu, Z. [1 ]
Pan, H. [2 ]
Ye, M. [3 ]
Chen, L. [4 ]
Qian, W. [4 ]
Zhang, J. [4 ]
机构：
[1] Univ Minnesota, Sci & Engn, Minneapolis, MN 55455 USA
[2] Guangzhou Med Univ, Affiliated Hosp 1, Translat Med, Guangzhou, Guangdong, Peoples R China
[3] Guangzhou Chest Hosp, Internal Med, Guangzhou, Guangdong, Peoples R China
[4] Guangzhou Med Univ, Affiliated Hosp 1, Internal Med, Guangzhou, Guangdong, Peoples R China
来源：
JOURNAL OF THORACIC ONCOLOGY | 2018年 / 13卷 / 10期
关键词：
Apatinib; advance NSCLC; VEGFR-2; inhibitors;
D O I：
10.1016/j.jtho.2018.08.1186
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P2.01-131
引用
收藏
页码：S715 / S715
页数：1
相关论文
共 50 条
  • [21] A retrospective study of low-dose apatinib combined with S-1 in patients with advanced non-small cell lung cancer
    Zhou, Tong
    Wu, Changling
    Zhang, Changsong
    Li, Peng
    Dong, Huajie
    Zhou, Xiaoyue
    Lu, Hongjun
    Qi, Chuang
    Ling, Yang
    JOURNAL OF THORACIC DISEASE, 2019, 11 (05) : 1831 - 1837
  • [22] Efficacy and safety of apatinib alone or apatinib plus paclitaxel/docetaxel versus paclitaxel/docetaxel in the treatment of advanced non-small cell lung cancer: A meta-analysis
    Li, Zhe
    Liu, Zhibao
    Wu, Yuanyuan
    Li, Huarui
    Sun, Zhen
    Han, Chenggang
    Zhang, Xiaoling
    Zhang, Jinghua
    THORACIC CANCER, 2021, 12 (21) : 2838 - 2848
  • [23] The effect of apatinib combined with chemotherapy or targeted therapy on non-small cell lung cancer in vitro and vivo
    Liu, Mingtao
    Wang, Xiuxiu
    Li, Hui
    Xu, Lisheng
    Jing, Lijun
    Jiang, Peng
    Liu, Baoyi
    Li, Yu
    THORACIC CANCER, 2019, 10 (10) : 1868 - 1878
  • [24] Hypertension as a predictive biomarker in patients with advanced non-small-cell lung cancer treated with apatinib
    Fang, Shen-Cun
    Huang, Wen
    Zhang, Ying-Ming
    Zhang, Hai-Tao
    Xie, Wei-Ping
    ONCOTARGETS AND THERAPY, 2019, 12 : 985 - 992
  • [25] Therapeutic strategies in advanced ALK positive non-small cell lung cancer
    Tiotiu, A.
    Billon, Y.
    Vaillant, P.
    Menard, O.
    Hofman, P.
    Mascaux, C.
    REVUE DES MALADIES RESPIRATOIRES, 2019, 36 (10) : 1107 - 1116
  • [26] The Efficacy of Apatinib Plus Topotecan as Laterline Therapy for Advanced Small Cell Lung Cancer
    Qin, H.
    Gao, H.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S792 - S793
  • [27] A Phase II Clinical Trial of Apatinib in Pretreated Advanced Non-squamous Non-small-cell Lung Cancer
    Wu, Fengying
    Zhang, Shijia
    Xiong, Anwen
    Gao, Guanghui
    Li, Wei
    Cai, Weijing
    Su, Chunxia
    Chen, Xiaoxia
    Zhou, Fei
    Zhao, Jing
    Ren, Shengxiang
    Zhou, Caicun
    CLINICAL LUNG CANCER, 2018, 19 (06) : E831 - E842
  • [28] Efficacy and safety of apatinib treatment for gastric cancer, hepatocellular carcinoma and non-small cell lung cancer: a meta-analysis
    Xue, Jin-min
    Astere, Manirakiza
    Zhong, Mao-xi
    Lin, Han
    Shen, Jin
    Zhu, Yu-xi
    ONCOTARGETS AND THERAPY, 2018, 11 : 6119 - 6128
  • [29] Treatment of Advanced Non-Small Cell Lung Cancer with RET Fusions: Reality and Hopes
    Rocco, Danilo
    Sapio, Luigi
    Della Gravara, Luigi
    Naviglio, Silvio
    Gridelli, Cesare
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (03)
  • [30] The role of combination chemo-immunotherapy in advanced non-small cell lung cancer
    Rocco, Danilo
    Della Gravara, Luigi
    Battiloro, Ciro
    Gridelli, Cesare
    EXPERT REVIEW OF ANTICANCER THERAPY, 2019, 19 (07) : 561 - 568
12345